Desk› Healthcare› Parmax Pharma Ltd

Parmax Pharma Ltd

BSE 540359 PARMAX INE240T01014

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Filing rhythm · 60 trading days

34 filings · 10 material · busiest 2026-08-14

What it files

General5 AGM / EGM5 SAST3 Newspaper Publication3 Insider / SAST3 Board Outcome3 Open Offer3 Results2

Filings

34 in the window

24 August 2026

General

Post Offer Advertisement

Fedex Securities Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Post Offer Advertisement in accordance with Regulations 18(12) of the Securities and Exchange Board of India ....

Company Update / General View filing →
24 August 2026

General

Intimation Of Reclassification Of Promoters Under Regulation 31A Of SEBI (LODR) Regulations, 2015

Intimation of Reclassification of Promoters under Regulations 31A of SEBI (LODR) Regulations, 2015

Company Update / General View filing →
17 August 2026

SAST

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dhiren Chandulal Shah, Sunil Chinubhai Shah & PACs

Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
17 August 2026

SAST

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Alkesh Mahasukhlal Gopani & Others

Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
17 August 2026

Newspaper Publication

Newspaper Publication

Newspaper publication of extract of Financial results of quarter ended June 30, 2026

Company Update / Newspaper Publication View filing →
14 August 2026

Insider / SAST

Disclosures under Reg. 18(6) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 18(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sunil Shah & Others

Insider Trading / SAST / Disclosures under Reg. 18(6) of SEBI (SAST) Regulations, 2011 View filing →
14 August 2026

Board Outcome

Board Meeting Outcome for Approval Of Unaudited Financial Results For Quarter Ended 30.06.2026

Outcome of Board Meeting as per attached

Board Meeting / Outcome of Board Meeting View filing →
14 August 2026

Results

Results For Quarter Ended June 30, 2026

Results for quarter ended June 30, 2026

Result / Financial Results View filing →
14 August 2026

Change in Management

Change in Management

Appointment of Mr. Dhiren Shah, Mr. Sunil Shah as an Additional Directors and recommendation of Ms. Anjana Shah, Ashish Shah as an Independent Directors subject to prior approval of shareholders ....

Company Update / Change in Management View filing →
11 August 2026

Board Meeting

Board Meeting Intimation for Approval Of Quarterly Financial Results For Quarter Ended June 30, 2026

Parmax Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve quarterly financial results for ....

Board Meeting / Board Meeting View filing →
29 July 2026

Open Offer

Updates on Open Offer

Fedex Securities Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of newspaper publication of Offer Opening Pre-Offer Advertisement to the Public Shareholders of Parmax Pharma ....

Company Update / Open Offer View filing →
27 July 2026

Open Offer

Updates on Open Offer

Fedex Securities Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of newspaper publication of Recommendations of the Committee of Independent Directors ('IDC') to the Public ....

Company Update / Open Offer View filing →
22 July 2026

General

Letter of Offer

Fedex Securities Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Letter of Offer for the attention of the Public Shareholders of Parmax Pharma Ltd ("Target Company").

Company Update / General View filing →
16 July 2026

Compliance Certificate

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Compliance Certificate for quarter ended June 30, 2026

Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
3 July 2026

AGM / EGM

Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

Scrutinizer report along with result of Evoting

AGM/EGM / EGM View filing →
2 July 2026

AGM / EGM

Shareholder Meeting / Postal Ballot-Outcome of EGM

Proceeding of 2nd Extra Ordinary General Meeting of the Company

AGM/EGM / EGM View filing →
2 July 2026

AGM / EGM

Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

Scrutinizer Report and Voting Results

AGM/EGM / EGM View filing →
2 July 2026

Charter Amendment

Amendments to Memorandum & Articles of Association

Amendments to Memorandum Of Association and Articles of Association of the Company

Company Update / Amendments to Memorandum & Articles of Association View filing →
29 June 2026

Trading Window

Closure of Trading Window

Trading window closure

Insider Trading / SAST / Closure of Trading Window View filing →
25 June 2026

Newspaper Publication

Newspaper Publication

Newspaper publication with respect to Corrigendum to EGM Notice

Company Update / Newspaper Publication View filing →
23 June 2026

General

Draft Letter of Offer

Fedex Securities Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Draft Letter of Offer for the attention of the Public Shareholders of Parmax Pharma Ltd ("Target Company").

Company Update / General View filing →
23 June 2026

SAST

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Pradeep Ramniklal Gosalia

Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
23 June 2026

AGM / EGM

Corrigendum To The Notice Of (2Nd/2026-27) Extraordinary General Meeting Of The Company

Corrigendum to the EGM Notice dated 8th June 2026

AGM/EGM / EGM View filing →
19 June 2026

Insider / SAST

Disclosures under Reg. 18(6) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 18(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sunil Chinubhai Shah & Dhiren Shah

Insider Trading / SAST / Disclosures under Reg. 18(6) of SEBI (SAST) Regulations, 2011 View filing →
17 June 2026

Insider / SAST

Disclosures under Reg. 18(6) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 18(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dhiren Chandulal Shah, Sunil Chinubhai Shah & PACs

Insider Trading / SAST / Disclosures under Reg. 18(6) of SEBI (SAST) Regulations, 2011 View filing →
15 June 2026

General

Detailed Public Statement

Fedex Securities Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Detailed Public Statement in terms of Regulations 3(1) and 4 read with Regulations 13(4), 14 (3) and 15(2) ....

Company Update / General View filing →
11 June 2026

Newspaper Publication

Newspaper Publication

Regarding Notice of EGM and E-voting

Company Update / Newspaper Publication View filing →
9 June 2026

Open Offer

Open Offer

Fedex Securities Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Public Announcement under Regulation 3(1) And Regulation 4 Read with Regulation 13, Regulation 14 And Regulation ....

Company Update / Open Offer View filing →
9 June 2026

Contract / MoU

Memorandum of Understanding /Agreements

Share purchase agreement and Public Announcement

Company Update / Memorandum of Understanding /Agreements View filing →
9 June 2026

AGM / EGM

EGM Scheduled To Be Held On July 02, 2026

Notice of EGM scheduled to be held on July 02, 2026

AGM/EGM / EGM View filing →
8 June 2026

Board Outcome

Board Meeting Outcome for Outcome Of Board Meeting

Issue of Shares and Warrants on Preferential basis pursuant to SEBI ICDR Regulations

Board Meeting / Outcome of Board Meeting View filing →
3 June 2026

Board Outcome

Board Meeting Outcome for Outcome Of Board Meeting

Reschedule of Boar Meeting and Outcome of Board Meeting

Board Meeting / Outcome of Board Meeting View filing →
3 June 2026

Results

Results-Delay in Financial Results

Results for Financial Results for Quarter and Financial Year ended March 31, 2026

Result / Financial Results View filing →
3 June 2026

Board Meeting

Board Meeting Intimation for Fund Raising

Parmax Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/06/2026 ,inter alia, to consider and approve Fund raising

Board Meeting / Board Meeting View filing →